Related Experiment Video
Updated: Aug 7, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
A case of pulmonary aspergillosis with lack of response to caspofungin
Reinhard Rüchel1, Christine Perske, Bertram Glass
1Department of Medical Microbiology, University Hospital of Göttingen, Göttingen, Germany. rrueche@gwdg.de
Abstract:
Currently, susceptibility testing of Aspergillus isolates towards caspofungin is hampered by a lack of interpretative cut-off values. Nevertheless, caspofungin has been widely recommended for the treatment of invasive aspergillosis. This antifungal, however, could lead to therapy failure as demonstrated by the case in this report of a 55-year-old patient, who eight months after the diagnosis of leukemia and successful allogenic hematopoietic stem cell transplantation (HSCT), succumbed to a fatal pulmonary aspergillosis infection, which resisted treatment with caspofungin.
Insights
Caspofungin is recommended for invasive aspergillosis, but a lack of testing standards can lead to treatment failure. This case highlights the risk of fatal outcomes despite antifungal use.
Area of Science:
- Mycology
- Infectious Diseases
- Hematology
Background:
- Invasive aspergillosis is a serious fungal infection, particularly in immunocompromised patients.
- Caspofungin is a widely recommended antifungal agent for treating invasive aspergillosis.
- Standardized susceptibility testing for Aspergillus species against caspofungin is lacking.
Observation:
- A 55-year-old patient with leukemia underwent successful allogeneic hematopoietic stem cell transplantation (HSCT).
- Eight months post-HSCT, the patient developed a fatal pulmonary aspergillosis infection.
- The infection was resistant to caspofungin treatment.
Findings:
- The case demonstrates a potential for therapy failure with caspofungin in invasive aspergillosis.
- Lack of interpretative cut-off values for caspofungin susceptibility testing hinders effective treatment selection.
- Aspergillus isolates can exhibit resistance to caspofungin, leading to poor clinical outcomes.
Implications:
- There is a critical need for standardized caspofungin susceptibility testing methods for Aspergillus.
- Clinical guidelines should address the management of invasive aspergillosis in HSCT recipients with potential antifungal resistance.
- Further research is required to understand and overcome caspofungin resistance mechanisms in Aspergillus.
Related Concept Videos
Cryptococcal Meningitis
Fungal Phylum Ascomycota
Candidiasis
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Atypical Pneumonia
Fungal Phylum Microsporidia